A Clinician's Pearls & Myths in Rheumatology, Kartoniert / Broschiert
A Clinician's Pearls & Myths in Rheumatology
Buch
lieferbar innerhalb 2-3 Wochen
(soweit verfügbar beim Lieferanten)
(soweit verfügbar beim Lieferanten)
Aktueller Preis: EUR 90,66
- Herausgeber:
- John H. Stone
- Verlag:
- Springer International Publishing, 04/2024
- Einband:
- Kartoniert / Broschiert, Paperback
- Sprache:
- Englisch
- ISBN-13:
- 9783031234903
- Artikelnummer:
- 11816119
- Umfang:
- 796 Seiten
- Nummer der Auflage:
- 24002
- Ausgabe:
- Second Edition 2023
- Gewicht:
- 2134 g
- Maße:
- 279 x 210 mm
- Stärke:
- 40 mm
- Erscheinungstermin:
- 1.4.2024
- Hinweis
-
Achtung: Artikel ist nicht in deutscher Sprache!
Weitere Ausgaben von A Clinician's Pearls & Myths in Rheumatology |
Preis |
|---|
Klappentext
This book builds upon the first edition with new and improved chapters. The book explores the rich assemblage of clinical wisdom from expert rheumatologists from a wide range of specialties including Vasculitis and Sjogren s syndrome. It examines the nuggets or pearls of wisdom gained from collective clinical experience about the diagnosis or treatment of various diseases whilst also aiming to debunk myths that have influenced the practice of rheumatology by many clinicians.The second edition of A Clinician's Pearls and Myths in Rheumatology is a critical resource for both practitioners and students of rheumatology. This book provides a clear guide for those wishing to take a deep dive into the diagnostic and therapeutic elements of rheumatology.
Biografie
John H. Stone, MD, MPH is Clinical Director of Rheumatology, Harvard Medical School, Boston, MA, USA and the Chairman of the International Network for the Study of the Systemic Vasculitides (INSSYS). Dr Stone's research interests relate to translational investigations in systemic vasculitis. He has directed two multicenter clinical trials in Wegener's granulomatosis and antineutrophil cytoplasmic antibody-associated vasculitis, the Wegener's Granulomatosis Etanercept Trial (WGET) and the Rituximab in ANCA-associated Vasculitis (RAVE) trial. His other research efforts relate to the identification of new biomarkers through proteomic approaches, and to the development of clinical trials' outcome measures in rheumatic autoimmune diseases
A Clinician's Pearls & Myths in Rheumatology
Aktueller Preis: EUR 90,66
